Top compounds associated with response to AAMDC


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.074 0.02
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.033 0.5
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.004 0.9
mRNA temsirolimus FIMM pan-cancer AAC -0.0087 1
mRNA thalidomide CTRPv2 pan-cancer AAC 0.12 0.03
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.065 0.07
mRNA thapsigargin gCSI pan-cancer AAC -0.089 0.1
mRNA tigecycline CTRPv2 pan-cancer AAC -0.034 0.5
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.056 0.07
Download CSV